Ms Carol Ann Lambert, MSW | |
5 Watson Rd, Belmont, MA 02478-3932 | |
(617) 484-2272 | |
Not Available |
Full Name | Ms Carol Ann Lambert |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 46 Years |
Location | 5 Watson Rd, Belmont, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073597969 | NPI | - | NPPES |
731896 | Other | MA | TUFTS |
040110000 | Other | MA | MAGELLAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 103521 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Carol Ann Lambert, MSW 87 Wolf Rock Rd, Carlisle, MA 01741-1129 Ph: (978) 369-0259 | Ms Carol Ann Lambert, MSW 5 Watson Rd, Belmont, MA 02478-3932 Ph: (617) 484-2272 |
News Archive
A multivitamin given daily to pregnant women in rural Bangladesh reduced pre-term births, increased infant birth weight and resulted in healthier babies overall, according to the large randomized trial conducted by Johns Hopkins Bloomberg School of Public Health researchers.
Nature News reports on last week's announcement of preliminary results from a large clinical trial testing the efficacy of GlaxoSmithKline's (GSK) RTS,S malaria vaccine, writing that while media coverage of the announcement touted it as a "big breakthrough in the long campaign to create a malaria vaccine," "several leading vaccine researchers, who are critical of the unusual decision to publish partial trial data, argue that the results raise questions about whether the RTS,S/AS01 candidate vaccine can actually win approval."
Older patients with Hodgkin lymphoma (HL) and a history of heart disease face a high risk of hospitalization for cardiac complications after completing treatment, according to research published online today in Blood, the journal of the American Society of Hematology. HL is a form of cancer of arising in the lymph nodes, and approximately 8,500 people were diagnosed with the disease in 2009, according to the American Cancer Society.
A protein thought to fuel pancreatic cancer development plays a much more complicated role, a new study finds.
Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure today announced that it has completed patient enrollment in its Phase 3 clinical study of vepoloxamer for the treatment of patients with sickle cell disease experiencing vaso-occlusive crisis, known as the EPIC study.
› Verified 4 days ago
Katy Tarella, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Mailstop 137, Belmont, MA 02478 Phone: 617-855-4178 | |
Miqveh Steinhart, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3118 | |
Joan Martha Cottler, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3623 | |
Perrie T Merlin, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-2321 | |
Brigitte Giber, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 51 Bow Rd, Belmont, MA 02478 Phone: 617-932-9564 | |
Ms. Megan Ray, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-4033 Fax: 617-855-3709 | |
Kaitlin Barnea, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3296 |